Quick Answer
PROCEPT BioRobotics Corp reported Operating Income Loss of -$103.86 million for the year ending 2025.
- PROCEPT BioRobotics Corp showed a decrease of -7.5% in Operating Income Loss from 2024 to 2025.
- This data is from PROCEPT BioRobotics Corp's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: -$10.98 million | Q1 2021: -$11.34 million | Q2 2021: -$13.19 million | Q3 2021: -$12.80 million | Q1 2022: -$15.70 million | Q2 2022: -$17.88 million | Q3 2022: -$22.11 million | Q1 2023: -$28.38 million | Q2 2023: -$25.63 million | Q3 2023: -$25.61 million | Q1 2024: -$27.65 million | Q2 2024: -$26.83 million | Q3 2024: -$22.43 million | Q1 2025: -$27.44 million | Q2 2025: -$22.19 million | Q3 2025: -$23.19 million.
- Over the full 6 years of available data (2020 to 2025), PROCEPT BioRobotics Corp's Operating Income Loss has declined by 117.3%.
- Historical annual values: Fiscal year 2025: -$103.86 million | Fiscal year 2024: -$96.61 million | Fiscal year 2023: -$109.17 million | Fiscal year 2022: -$80.72 million | Fiscal year 2021: -$54.16 million | Fiscal year 2020: -$47.80 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: